Join us for exciting keynote presentations and numerous networking opportunities with experts, researchers, and up-and-coming leaders in the field of Regenerative Medicine.


Head of the Wake Forest Regenerative
Medicine Institute

Anthony Atala, MD is the Director of the Wake Forest Institute for Regenerative Medicine, and the W.H. Boyce Professor and Chair of the Department of Urology at Wake Forest University. Dr. Atala is a practicing surgeon and a researcher in the area of regenerative medicine, focusing on growing new human cells, tissues and organs.


Case Western Reserve University
Director, Skeletal Research Center

Arnold Caplan, Ph.D is a national and international scholar focusing on experimentation in the area of musculoskeletal and skin development. He has published over 400 papers and manuscripts and has been supported by the NIH and other non-profit and for-profit agencies for his efforts in trying to understand the development, maturation, and aging of cartilage, bone, skin, and other mesenchymal tissues and his pioneering research on Mesenchymal Stem Cells.


Professor, Harvard & Massachusetts Institute of Technology

George Church is Professor of Genetics at Harvard Medical School and Director of PersonalGenomes.org, which provides the world’s only open-access information on human Genomic, Environmental and Trait data. He is co-author of 480 papers, 130 patent publications and the book “Regenesis”, developed methods used for the first genome sequence and million-fold cost reductions since, plus barcoding, DNA assembly from chips, genome editing, writing and recoding.


Chief Science Officer and Co-Founder, SENS Research Foundation

Aubrey de Grey is the biomedical gerontologist who researched the idea for and founded SENS Research Foundation. He received his BA in Computer Science and Ph.D. in Biology from the University of Cambridge. Dr. de Grey is Editor-in-Chief of Rejuvenation Research, is a Fellow of both the Gerontological Society of America and the American Aging Association and sits on the editorial and scientific advisory boards of numerous journals and organizations.


Director, Harvard Stem Cell Institute

Brock Reeve is Executive Director of the Harvard Stem Cell Institute. In partnership with the Faculty Directors, oversees the operations and strategy of the Institute whose mission is to use stem cells, both as tools and as therapies, to understand and treat the root causes of leading degenerative diseases. The Institute is engaged with several leading pharmaceutical companies in joint research projects and its faculty have founded several stem cell-related startup companies.


Chief Medical Officer, Black Beret Life Sciences
Interventional Cardiologist, Okyanos

Dr. Warren Sherman, MD is a renowned interventional cardiologist with a long and established focus in cell-based therapies. As Chief Medical Officer and a treating physician at Okyanos, Dr. Sherman provides the highest level of care using stem cell therapies for patients with chronic heart failure and refractory angina. Dr. Sherman pioneered a technique for injecting stem cells into the heart and was the first to perform the procedure on a patient.


President, Gladstone Institutes
Director, Roddenberry Institute

Dr. Deepak Srivastava is the Younger Family Director and a Senior Investigator at the Gladstone Institute of Cardiovascular Disease and Director of the Roddenberry Center for Stem Cell Biology at Gladstone. At the University of California, San Francisco (UCSF), Dr. Srivastava is also a Professor in the Departments of Pediatrics, and Biochemistry & Biophysics, and is the Wilma and Adeline Pirag Distinguished Professor in Pediatric Developmental Cardiology.